ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2187

A Low Cartilage Formation & Repair Endotype Predicts Radiographic Progression in Symptomatic Knee Osteoarthritis Patients and Identifies Optimal Responders to a Potential OA Treatment

Yunyun Luo 1, Jonathan Samuels 2, Svetlana Krasnokutsky 3, Inger Byrjalsen 1, Jeppe Andersen 4, Asger Bihlet 5, Yi He 1, Morten Karsdal 6, Steven Abramson 7, Mukundan Attur 3 and Anne Bay-Jensen1, 1Nordic Bioscience, Herlev, Denmark, 2NYU Langone Medical Center, New Yort, NY, 3NYU School of Medicine and NYU Langone Orthopedic Hospital, New York City, NY, 4Nordic Bioscience, Clinical development, Herlev, Denmark, 5Nordic Bioscience Clinical Development, Herlev, Denmark, 6Nordic Bioscience, Copenhagen, Denmark, 7NYU School of Medicine and NYU Langone Orthopedic Hospital, New York, NY

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Biomarkers, Calcitonin, Osteoarthritis, radiographic and cartilage

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Tuesday, November 12, 2019

Session Title: Osteoarthritis – Clinical Poster II

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoarthritis (OA) is a highly heterogeneous disease, which suggest that multiple endotypes exist. Identification and characterization of such endotypes may assist in precision medicine for identification of faster progressors whom may benefit from a given type of intervention. Recent published data have shown that SNPs in growth factors such as TGFbeta and GDF are associated with OA, which indicate that cartilage formation and repair play an important role in progression of OA. The aim was to determine whether a biomarker of type II collagen formation measured in serum, as a potential surrogate measure of cartilage formation, could predict radiographic progression in knee OA population. Subsequently, we investigated if such a proposed low cartilage formation/repair endotype was more responsive to a potential treatment of OA.

Methods: hsPRO-C2, a measurement of the type II collagen pro-peptide, was measured in blood samples of two independent knee OA cohorts: 106 recruited at New York University (NYU cohort) and 147 from the phase III OA trial SMC021-2301 (clinicaltrial.gov: NCT00486434) evaluating the efficacy and safety of oral salmon calcitonin. Patients were dichotomized based on their baseline level of hsPRO-C2 and the mean difference in two-year radiographic progression (joint space narrowing (JSN)) was analyzed using ANCOVA adjusting for baseline demographics and clinical characteristics.

Results: In the NYU cohort, baseline plasma hsPRO-C2 levels were negatively correlated with the progression of radiographic JSN (r = -0.26, p = 0.009). Quartile analysis demonstrated a significant difference in mean JSN from quartile 1 to 4 (0.51 mm versus -0.07 mm, p = 0.036, fig. 1). Knee OA patients with low hsPRO-C2 levels (≤ 1.48 ng/mL) revealed significantly larger JSN compared to the individuals with high hsPRO-C2 levels ( > 1.48 ng/mL) at 24 months (0.37 mm vs 0.02 mm, p = 0.042). In the SMC cohort, there was no significant treatment effect on the medial JSN over 2 years before stratification by hsPRO-C2; however, as observed in the NYU cohort, JSN was on average higher in the low hsPRO-C2 (≤ 1.96 ng/mL) group compared to the high group ( > 1.96 ng/mL). Furthermore, in the low baseline hsPRO-C2 subgroup, sCT-treated patients on average had a lower JSN compared to placebo patients (p < 0.05, fig. 2). The opposite trend was observed in patients with high baseline hsPRO-C2.

Conclusion: Here we show that low levels of cartilage formation, measured by PRO-C2, were associated with radiographic progression and greater likelihood of response to a salmon calcitonin. Low PRO-C2 may provide a measure of an OA endotype with low background cartilage formation (at baseline) and higher capacity for repair when treated with a potential cartilage anabolic drug.

Fig. 1. Two-year joint space narrowing in OA patients divided into quartiles based on baseline levels of plasma PRO-C2.

Fig. 2. Two-year joint space arrowing in stratified patients treated with placebo or sCT.


Disclosure: Y. Luo, None; J. Samuels, None; S. Krasnokutsky, None; I. Byrjalsen, Nordic Bioscience, 3, Nordic Bioscience Clinical Development, 3; J. Andersen, Nordic Bioscience, 1, 3, 6; A. Bihlet, Nordic Bioscience, 1, 3, Nordic Bioscience Clinical Development, 3; Y. He, Nordic Bioscience, 3; M. Karsdal, Nordic Biosceince, 1, 3, Nordic Bioscience, 1, 2, 3, 4, 5; S. Abramson, None; M. Attur, None; A. Bay-Jensen, Nordic Bioscience, 1, 2, 3.

To cite this abstract in AMA style:

Luo Y, Samuels J, Krasnokutsky S, Byrjalsen I, Andersen J, Bihlet A, He Y, Karsdal M, Abramson S, Attur M, Bay-Jensen A. A Low Cartilage Formation & Repair Endotype Predicts Radiographic Progression in Symptomatic Knee Osteoarthritis Patients and Identifies Optimal Responders to a Potential OA Treatment [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/a-low-cartilage-formation-repair-endotype-predicts-radiographic-progression-in-symptomatic-knee-osteoarthritis-patients-and-identifies-optimal-responders-to-a-potential-oa-treatment/. Accessed January 20, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-low-cartilage-formation-repair-endotype-predicts-radiographic-progression-in-symptomatic-knee-osteoarthritis-patients-and-identifies-optimal-responders-to-a-potential-oa-treatment/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.